Literature DB >> 20527891

Selective synthesis and biological evaluation of sulfate-conjugated resveratrol metabolites.

Juma Hoshino1, Eun-Jung Park, Tamara P Kondratyuk, Laura Marler, John M Pezzuto, Richard B van Breemen, Shunyan Mo, Yongchao Li, Mark Cushman.   

Abstract

Five resveratrol sulfate metabolites were synthesized and assessed for activities known to be mediated by resveratrol: inhibition of tumor necrosis factor (TNF) alpha induced NFkappaB activity, cylcooxygenases (COX-1 and COX-2), aromatase, nitric oxide production in endotoxin-stimulated macrophages, proliferation of KB or MCF7 cells, induction of quinone reductase 1 (QR1), accumulation in the sub-G(1) phase of the cell cycle, and quenching of 2,2-diphenyl-1-picrylhydrazyl (DPPH) free radical. Two metabolites showed activity in these assays; the 3-sulfate exhibited QR1 induction, DPPH free radical scavenging, and COX-1 and COX-2 inhibitory activities and the 4'-sulfate inhibited NFkappaB induction, as well as COX-1 and COX-2 activities. Resveratrol and its 3'-sulfate and 4-sulfate inhibit NO production by NO scavenging and down-regulation of iNOS expression in RAW 264.7 cells. Resveratrol sulfates displayed low antiproliferative activity and negligible uptake in MCF7 cells.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20527891      PMCID: PMC2917805          DOI: 10.1021/jm100274c

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  86 in total

1.  Rapid and efficient microwave-assisted synthesis of highly sulfated organic scaffolds.

Authors:  Arjun Raghuraman; Muhammad Riaz; Michael Hindle; Umesh R Desai
Journal:  Tetrahedron Lett       Date:  2007-09-17       Impact factor: 2.415

2.  Suppression of cell proliferation by inhibition of estrone-3-sulfate transporter in estrogen-dependent breast cancer cells.

Authors:  Takashi Nozawa; Masato Suzuki; Hikaru Yabuuchi; Masanori Irokawa; Akira Tsuji; Ikumi Tamai
Journal:  Pharm Res       Date:  2005-09-22       Impact factor: 4.200

3.  Bioactivity and metabolism of trans-resveratrol orally administered to Wistar rats.

Authors:  Elisabeth Wenzel; Tomislav Soldo; Helmut Erbersdobler; Veronika Somoza
Journal:  Mol Nutr Food Res       Date:  2005-05       Impact factor: 5.914

4.  Effect of plasma metabolites of (+)-catechin and quercetin on monocyte adhesion to human aortic endothelial cells.

Authors:  T Koga; M Meydani
Journal:  Am J Clin Nutr       Date:  2001-05       Impact factor: 7.045

5.  Characterization of immunological activities of peanut stilbenoids, arachidin-1, piceatannol, and resveratrol on lipopolysaccharide-induced inflammation of RAW 264.7 macrophages.

Authors:  Bambang Djoko; Robin Y-Y Chiou; Jia-Jen Shee; Yi-Wen Liu
Journal:  J Agric Food Chem       Date:  2007-02-23       Impact factor: 5.279

6.  New colorimetric cytotoxicity assay for anticancer-drug screening.

Authors:  P Skehan; R Storeng; D Scudiero; A Monks; J McMahon; D Vistica; J T Warren; H Bokesch; S Kenney; M R Boyd
Journal:  J Natl Cancer Inst       Date:  1990-07-04       Impact factor: 13.506

7.  Suppression of 7,12-dimethylbenz(a)anthracene-induced mammary carcinogenesis in rats by resveratrol: role of nuclear factor-kappaB, cyclooxygenase 2, and matrix metalloprotease 9.

Authors:  Sanjeev Banerjee; Carlos Bueso-Ramos; Bharat B Aggarwal
Journal:  Cancer Res       Date:  2002-09-01       Impact factor: 12.701

8.  Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan.

Authors:  Konrad T Howitz; Kevin J Bitterman; Haim Y Cohen; Dudley W Lamming; Siva Lavu; Jason G Wood; Robert E Zipkin; Phuong Chung; Anne Kisielewski; Li-Li Zhang; Brandy Scherer; David A Sinclair
Journal:  Nature       Date:  2003-08-24       Impact factor: 49.962

Review 9.  Role of reactive intermediates in tumor promotion and progression.

Authors:  T Kensler; K Guyton; P Egner; T McCarthy; S Lesko; S Akman
Journal:  Prog Clin Biol Res       Date:  1995

10.  Molecular mechanisms of resveratrol action in lung cancer cells using dual protein and microarray analyses.

Authors:  Lorna Whyte; Yuan-Yen Huang; Karen Torres; Rajendra G Mehta
Journal:  Cancer Res       Date:  2007-12-15       Impact factor: 12.701

View more
  54 in total

1.  Determination of resveratrol and its sulfate and glucuronide metabolites in plasma by LC-MS/MS and their pharmacokinetics in dogs.

Authors:  Miguel Muzzio; Zhihua Huang; Shu-Chieh Hu; William D Johnson; David L McCormick; Izet M Kapetanovic
Journal:  J Pharm Biomed Anal       Date:  2011-10-25       Impact factor: 3.935

Review 2.  Resveratrol biosynthesis: plant metabolic engineering for nutritional improvement of food.

Authors:  Giovanna Giovinazzo; Ilaria Ingrosso; Annalisa Paradiso; Laura De Gara; Angelo Santino
Journal:  Plant Foods Hum Nutr       Date:  2012-09       Impact factor: 3.921

3.  Herb-drug interactions: challenges and opportunities for improved predictions.

Authors:  Scott J Brantley; Aneesh A Argikar; Yvonne S Lin; Swati Nagar; Mary F Paine
Journal:  Drug Metab Dispos       Date:  2013-12-11       Impact factor: 3.922

4.  Resveratrol derivatives as promising chemopreventive agents with improved potency and selectivity.

Authors:  Tamara P Kondratyuk; Eun-Jung Park; Laura E Marler; Soyoun Ahn; Yang Yuan; Yongsoo Choi; Rui Yu; Richard B van Breemen; Bin Sun; Juma Hoshino; Mark Cushman; Katherine C Jermihov; Andrew D Mesecar; Clinton J Grubbs; John M Pezzuto
Journal:  Mol Nutr Food Res       Date:  2011-06-29       Impact factor: 5.914

5.  Complexes of the outer mitochondrial membrane protein mitoNEET with resveratrol-3-sulfate.

Authors:  Waqar Arif; Shu Xu; Dragan Isailovic; Werner J Geldenhuys; Richard T Carroll; Max O Funk
Journal:  Biochemistry       Date:  2011-06-02       Impact factor: 3.162

Review 6.  Targeting extracellular matrix remodeling in disease: Could resveratrol be a potential candidate?

Authors:  Renu Agarwal; Puneet Agarwal
Journal:  Exp Biol Med (Maywood)       Date:  2016-10-23

7.  Main constituents of polyphenol complex from seagrasses of the genus Zostera, their antidiabetic properties and mechanisms of action.

Authors:  Olga Nikolaevna Styshova; Alexander Michailovich Popov; Alexander Alekseevish Artyukov; Anna Anatolievna Klimovich
Journal:  Exp Ther Med       Date:  2017-03-10       Impact factor: 2.447

8.  Optimization of thiazole analogues of resveratrol for induction of NAD(P)H:quinone reductase 1 (QR1).

Authors:  Abdelrahman S Mayhoub; Laura Marler; Tamara P Kondratyuk; Eun-Jung Park; John M Pezzuto; Mark Cushman
Journal:  Bioorg Med Chem       Date:  2012-10-23       Impact factor: 3.641

9.  In vivo-formed versus preformed metabolite kinetics of trans-resveratrol-3-sulfate and trans-resveratrol-3-glucuronide.

Authors:  Satish Sharan; Otito F Iwuchukwu; Daniel J Canney; Cheryl L Zimmerman; Swati Nagar
Journal:  Drug Metab Dispos       Date:  2012-07-17       Impact factor: 3.922

Review 10.  Resveratrol and clinical trials: the crossroad from in vitro studies to human evidence.

Authors:  Joao Tomé-Carneiro; Mar Larrosa; Antonio González-Sarrías; Francisco A Tomás-Barberán; María Teresa García-Conesa; Juan Carlos Espín
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.